Posted by Michael Wonder on 11 Feb 2021
BrainQ gets FDA breakthrough status for its device for reducing disability following stroke
11 February 2021 - The breakthrough device designation, which comes after new trial data, is expected to expedite the device's path to market.
BrainQ announced today that the United States FDA has designated its AI powered technology as a breakthrough device.
